| Product Code: ETC10602606 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, the import shipments of Human Papilloma Virus vaccine to Ireland continued to be dominated by key suppliers such as the USA, UK, Germany, Metropolitan France, and Serbia. The high concentration of the Herfindahl-Hirschman Index (HHI) indicates a significant market share held by these countries. However, the compound annual growth rate (CAGR) for the period 2020-2024 was negative at -4.18%, with a steep decline in growth rate from 2023 to 2024 at -30.16%. This data suggests a challenging market environment for HPV vaccine imports in Ireland, possibly influenced by various factors impacting demand or supply.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Human Papilloma Virus Vaccine Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Human Papilloma Virus Vaccine Market - Industry Life Cycle |
3.4 Ireland Human Papilloma Virus Vaccine Market - Porter's Five Forces |
3.5 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Age Group Targeted, 2021 & 2031F |
3.7 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.8 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.9 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Ireland Human Papilloma Virus Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of HPV vaccination in preventing cervical cancer |
4.2.2 Government initiatives and programs promoting HPV vaccination |
4.2.3 Growing focus on preventive healthcare measures |
4.3 Market Restraints |
4.3.1 High cost associated with HPV vaccines |
4.3.2 Limited accessibility to vaccination services in remote areas |
4.3.3 Vaccine hesitancy and misinformation among the population |
5 Ireland Human Papilloma Virus Vaccine Market Trends |
6 Ireland Human Papilloma Virus Vaccine Market, By Types |
6.1 Ireland Human Papilloma Virus Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume, By Quadrivalent Vaccine, 2021 - 2031F |
6.1.4 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume, By Bivalent Vaccine, 2021 - 2031F |
6.2 Ireland Human Papilloma Virus Vaccine Market, By Age Group Targeted |
6.2.1 Overview and Analysis |
6.2.2 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume, By Children/Adolescents, 2021 - 2031F |
6.2.3 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume, By Young Adults, 2021 - 2031F |
6.3 Ireland Human Papilloma Virus Vaccine Market, By Formulation Type |
6.3.1 Overview and Analysis |
6.3.2 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.3 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4 Ireland Human Papilloma Virus Vaccine Market, By Application Area |
6.4.1 Overview and Analysis |
6.4.2 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume, By Cervical Cancer Prevention, 2021 - 2031F |
6.4.3 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume, By HPV Type 16 & 18 Prevention, 2021 - 2031F |
6.5 Ireland Human Papilloma Virus Vaccine Market, By End Use |
6.5.1 Overview and Analysis |
6.5.2 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume, By Public Health Programs, 2021 - 2031F |
6.5.3 Ireland Human Papilloma Virus Vaccine Market Revenues & Volume, By School Health Programs, 2021 - 2031F |
7 Ireland Human Papilloma Virus Vaccine Market Import-Export Trade Statistics |
7.1 Ireland Human Papilloma Virus Vaccine Market Export to Major Countries |
7.2 Ireland Human Papilloma Virus Vaccine Market Imports from Major Countries |
8 Ireland Human Papilloma Virus Vaccine Market Key Performance Indicators |
8.1 Percentage increase in HPV vaccine coverage rates among the target population |
8.2 Number of educational campaigns and awareness programs conducted |
8.3 Rate of vaccination uptake among different age groups |
8.4 Incidence rate of HPV-related diseases in Ireland |
8.5 Number of healthcare facilities offering HPV vaccination services |
9 Ireland Human Papilloma Virus Vaccine Market - Opportunity Assessment |
9.1 Ireland Human Papilloma Virus Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Ireland Human Papilloma Virus Vaccine Market Opportunity Assessment, By Age Group Targeted, 2021 & 2031F |
9.3 Ireland Human Papilloma Virus Vaccine Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.4 Ireland Human Papilloma Virus Vaccine Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.5 Ireland Human Papilloma Virus Vaccine Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Ireland Human Papilloma Virus Vaccine Market - Competitive Landscape |
10.1 Ireland Human Papilloma Virus Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Ireland Human Papilloma Virus Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |